期刊文献+

丙型肝炎病毒F蛋白在病毒复制和致病中的作用 被引量:6

Role of Hepatitis C Virus F Protein in Virus Replication and Pathogenesis
原文传递
导出
摘要 丙型肝炎病毒(Hepatitis C virus,HCV)属于黄病毒科,是有包膜的单正链RNA病毒。HCV基因组约有9 600个碱基,编码的单一开放读码框(Open reading frame,ORF)翻译出约3 000个氨基酸残基的多聚蛋白前体,在宿主细胞及病毒蛋白酶的作用下,剪切成至少10种结构蛋白和非结构蛋白。近年来,一种新的病毒蛋白在一些实验室相继被发现,称为读码框移位蛋白(Alternative reading frame protein,ARFP),或称为F蛋白(Frameshift protein),也有学者称之为Core+1蛋白。F蛋白是由核心基因读码框移位产生的,虽然从发现至今已有10余年,但其生物学功能仍不明确,对其在肝脏疾病和肝细胞癌的发生发展中的作用及其对HCV复制和感染的影响尚有争议。本文就F蛋白的发现、产生机制、抗原性、生化特性及生物学功能等作一综述。 Hepatitis C virus(HCV) is an enveloped positive-strand RNA virus of the Flaviviridae family,of which the genome consists of about 9 600 nucleotides encoding a polyprotein(about 3 000 amino acids) that is processed by cellular and viral proteases into at least ten structural and nonstructural viral proteins.In recent years,a novel HCV protein has been identified by several laboratories,known as the reading frame shift protein(alternative reading frame protein,ARFP) or F protein(frameshift protein),also called as Core+1 protein.F protein gene is generated from the core reading frame shift.Although F protein has been discovered for more than 10 years,its function remains unclear,and its role in genesis and progress of liver diseases and hepatocellular carcinoma(HCC) as well as its effect on replication and infection of HCV are still in dispute.This review aims to summary the discovery,mechanism,antigenicity,biochemical characteristics and biological function of F protein.
作者 王文博 任浩
出处 《中国生物制品学杂志》 CAS CSCD 2011年第3期349-353,共5页 Chinese Journal of Biologicals
基金 军队"十一五"医药卫生科研基金(06Z027 06H021) 国家自然科学基金(30872247 30600529) 上海市重点学科(B901) 第二军医大学"优秀硕士研究生苗子培育基金"(校研[2010]90号)
关键词 丙型肝炎病毒 F蛋白 重叠读码框 核糖体漂移 病毒复制 毒力 Hepatitis C virus(HCV) F protein Overlapping reading frame Ribosomal drift Virus replication Virulence
  • 相关文献

参考文献34

  • 1Poynard T, Yuen MF, Ratziu V, et al. Viral hepatitis C [J]. Lancet, 2003, 362 (9401): 2095-2100.
  • 2Houghton M, Abrignani S. Prospects for a vaccine against the hepatitis C virus [J]. Nature, 2005, 436 (7053): 961-966.
  • 3Bartenschlager R, Frese M, Pietschmann T. Now:l insights into hepatitis C virus replication and persistence [J]. Adv Virus Res, 2004, 63 : 71 - 180.
  • 4Walewski JL, Keller TR, Stump DD, et al. HCV-infected patients produce antibodies against a protein encoded in a second reading frame [J]. Hepatology, 1998, 28(4Pt 2): 278A.
  • 5Walewski JL, Keller TR, Stump DD, et al. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame [J]. RNA, 2001, 7 (5): 710-721.
  • 6Xu Z, Choi J, Yen TS, et al. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift [J]. EMBO J, 2001, 20 ( 14): 3840-3848.
  • 7Choi J, Xu Z, Ou JH. Triple decoding of hepatitis C virus RNA by programmed translational frameshifting [J]. Mol Cell Biol, 2003, 23 (5): 1489-1497.
  • 8Vassilaki N, Boleti H, Mavromara P. Expression studies of the HCV-la core+1 open reading frame in mammalian ceils [J]. Virus Res, 2008, 133 (2): 123-135.
  • 9Boulant S, Becchi M, Penin F, et al. Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b [J]. J Biol Chem, 2003, 278 (46): 45785- 45792.
  • 10Pawlotsky JM, Morice Y, Miladi A, et al. Presented at the 12th International Symposium on Hepatitis C Virus and Related Viruses [C]. (2005) Montreal, Canada.

同被引文献43

  • 1Maria M, Jordi G, Juan IE, et al. High-thoughput realtime reverse ranscription-PCR quantitation of HCVRNA. ] Clin Microbiol,1999, 37:327-332.
  • 2Kandi K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet,1992,339:1543.
  • 3Liew M, Erali M, Page S, et al. Hepatitis C genotyping by denatu- ring high-performance liquid chromatography. Clztt Microbiol, 2004,42 ( 1 ) : 158-163.
  • 4Etsuro Oxito. HCV genotype/serotype. Japanese clinical, 2001,59 (7) :1356.
  • 5Verachai V, Phutiprawan T. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thai- land. Southeast Asian J Trop Ned Public Health,2002,33 : 849 -851.
  • 6Mellor J, Walsh EA, Prescon LE, et al. Survey of type 6 group va- riants of hepatitis C virus in Southeast Asia by using a cow-based genotyping assay. J Clin Microbiol, 1996,34 (2) :417-423.
  • 7Dale MN, Wang XH, Shruti HM, et al. Hepatitis C Virus (HCV) coreantigen assay to detect ongoing HCV infect ion in Thai In jection drug users [J]. J Clin Microbiol, 2004, 42 (4) : 1631- 1636.
  • 8Martro E, Gonzalez V, Buckton A J, et al. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5'Noncoding and nonstructural 5b genomic regions [J]. J Clin Micro, 2008, 46 (1): 192-197.
  • 9Hansurabhanon T, Jiraphongsa C, Tunsakun P, et al. Infection with hepatitis C virus among intravenous-drug user: prevalence,g enotypes and risk-factor-associated be haviour patterns in Thailand [J]. Ann Trop Parasito, 2002, 96 (6): 615-625.
  • 10Simmonds P, Holmes E C, Cha T A, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region[J]. J Gen Virol, 2003,74 (11): 2391-2399.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部